Young India counts on ideas - Sahara Time, Richcore India

Young India counts on ideas

And in the process it is innovating and laying the foundation for a quantum jump in the frontier area of biotech

value to the customer.

Not many could achieve what Subramani has done in his short career. According to him the road from an engineering student to CEO of a biotech firm was not easy. He is an engineer and got an MBA degree from Indian School of Business (ISB) and has over six years of experience in biotech industry. After finishing his engineering in 1997 he was unable to find any job and opt for started doing event management. At the same time he also applied for job in Biocon. He shut down the event management business after six months when Biocon called him. He joined Biocon in 1998. "I was practically trained in Biocon," recalls Subramani. In Biocon he got the opportunity to share his innovative ideas with the biotech queen Kiran Mazumdar Shaw. "She kept on telling me to innovate," he adds.

Subramani got the inspiration from Shaw and started his own biotech firm in 2001. From a one-bedroom office in his house Richcore was incorporated as a 'Pvt Ltd' company. "We introduce innovative biotech formulations to conventional industries, our solutions are designed to improve process efficiencies. We also provide global marketing services to pharmaceutical and nutraceutical companies in the US, EU as well as in unregulated markets," says Subramani.

The most revenue-earning segment of Richcore is industrial enzymes; and has already developed several enzyme formulations, which have found acceptance with the industry.

In India the textile industry holds the maximum share of enzyme consumption. Enzymes have found wide application in the textile industry for improving production methods

and fabric finishing. Enzymes are typically very large protein molecules (bio-molecules), which act as catalysts and increase the speed of a chemical reaction without themselves undergoing any permanent chemical change. In the textile industry a new enzymatic activity has been introduced. This industry is under considerable environmental pressure owing to its large consumption of energy and water and

Richcore will manufacture these formulations and market them using its dedicated marketing and distributor network. The company sources enzymes from multiple sources and ensures that enzyme formulations have been developed using complementary strengths of enzymes produced by different manufacturers. "We add value to the enzymes collected from multiple sources and make it more stronger and productive for industrial use," says Subramani. This strengthens the fact of the inability to duplicate Richcore's formulations by its competitors, he adds.

According to Subramani, Richcore enzyme products are manufactured with strict quality controls in line with international norms. "We produce formulations of the enzymes for varied applications like Amylases, Amyloglucosidases, Catalase, Glucanases, Hemicellulases, Lipases, Pectinases, Proteases, Phytases.

Subramani finds strong research and development (R&D) activity behind the success of his plans. "Around 30 per cent of our sales, that is around Rs 5 lakh goes for R&D activity every month. We are also talking to Indian Institute of Science (IIS), Bangalore to provide us space for our R&D facilities," says Subramani.

With a turnover of around Rs 10 crore the company plans to enter into " Stem cell research" by associating with hospitals across the country in the near future. It also plans to expand the application of its technology in industrial applications like tissue culture/ horticulture/floriculture, food preservation, packing and medical applications. The R&D division will also undertake contract research in the near future and eventually venture into high-end pharmaceutical research.

Yogesh Tiwari

B IOTECH has caught the fancy of the bold new entrepreneurs. Subramani Ramchandappa, 30, founder and CEO of Richcore India, is one such young and talented entrepreneur who took this biopharmaceutical organisation to newer heights.

Richcore India is a Bangalore-based biopharmaceutical company founded by Subramani in 2001. The company encourages conventional

industries to use biotech solutions. Richcore solutions include use of microbial cultures, enzymes and active bio-systems. The enzyme act as essential raw material to diverse industries like textiles, leather, detergents, etc.

Richcore is also providing global marketing services to renowned pharmaceutical and nutraceutical companies with GMP and WHO certified facilities. Their area of operation includes catering to markets in the US, Middle East and Sri Lanka. The company has an overseas branch in Washington. The objective of the company remains to add

subsequent environmental pollution.

It is expected that within 10 years textile production will be shifted substantially due to increasing governmental and environmental restrictions and the availability of fresh water. Enzyme technology is a promising technology to fulfill expected future requirements and it is one way to attain leadership in traditional textile wet processing areas by both protecting the environment and reducing energy and chemical needs.



Young India counts on ideas And in the process it is innovating and laying the foundation for a quantum jump in the frontier area of biotech

		value to the customer. Not many could achieve what Subramani has done in his short career. According to him the road from an engineering student to CEO of a biotech firm was not easy. He is an engineer and got an MBA degree from Indian School of Business (ISB) and has over six years of experience in biotech industry. After finishing his engineering in 1997 he was unable to find any job and opt for started doing event management. At the same time he also applied for job in Biocon. He shut down the event management business after six months when Biocon called him. He joined Biocon in 1998. "I was practically trained in Biocon," recalls Subramani. In Biocon he got the opportunity to share his innovative ideas with the biotech queen Kiran Mazumdar Shaw. "She kept on telling me to innovate," he adds. Subramani got the inspiration from Shaw and started his own biotech firm in 2001. From a one-bedroom office in his house Richcore was incorporated as a 'Pvt Ltd' company. "We introduce innovative biotech formulations to conventional industries, our solutions are designed to improve process efficiencies. We also provide global marketing services to pharmaceutical and nutraceutical companies in the US, EU as well as in unregulated markets," says Subramani. The most revenue-earning segment of Richcore is industrial enzymes; and has already developed several enzyme formulations, which have found acceptance with the industry. In India the textile industry holds the maximum share of enzyme consumption. Enzymes have found wide application in the textile industry for improving production methods	and fabric finishing. Enzymes are typically very large protein molecules (bio-molecules), which act as catalysts and increase the speed of a chemical reaction without themselves undergoing any permanent chemical change. In the textile industry a new enzymatic activity has been introduced. This industry is under considerable environmental pressure owing to its large consumption of energy and water and	Richcore will manufacture these formulations and market them using its dedicated marketing and distributor network. The company sources enzymes from multiple sources and ensures that enzyme formulations have been developed using complementary strengths of enzymes produced by different manufacturers. "We add value to the enzymes collected from multiple sources and make it more stronger and productive for industrial use," says Subramani. This strengthens the fact of the inability to duplicate Richcore's formulations by its competitors, he adds. According to Subramani, Richcore enzyme products are manufactured with strict quality controls in line with international norms. "We produce formulations of the enzymes for varied applications like Amylases, Amyloglucosidases, Catalase, Glucanases, Hemicellulases, Lipases, Pectinases, Proteases, Phytases. Subramani finds strong research and development (R&D) activity behind the success of his plans. "Around 30 per cent of our sales, that is around Rs 5 lakh goes for R&D activity every month. We are also talking to Indian Institute of Science (IIS), Bangalore to provide us space for our R&D facilities," says Subramani. With a turnover of around Rs 10 crore the company plans to enter into " Stem cell research" by associating with hospitals across the country in the near future. It also plans to expand the application of its technology in industrial applications like tissue culture/ horticulture/floriculture, food preservation, packing and medical applications. The R&D division will also undertake contract research in the near future and eventually venture into high-end pharmaceutical research.

Yogesh Tiwari B IOTECH has caught the fancy of the bold new entrepreneurs. Subramani Ramchandappa, 30, founder and CEO of Richcore India, is one such young and talented entrepreneur who took this biopharmaceutical organisation to newer heights. Richcore India is a Bangalore-based biopharmaceutical company founded by Subramani in 2001. The company encourages conventional	industries to use biotech solutions. Richcore solutions include use of microbial cultures, enzymes and active bio-systems. The enzyme act as essential raw material to diverse industries like textiles, leather, detergents, etc. Richcore is also providing global marketing services to renowned pharmaceutical and nutraceutical companies with GMP and WHO certified facilities. Their area of operation includes catering to markets in the US, Middle East and Sri Lanka. The company has an overseas branch in Washington. The objective of the company remains to add
			subsequent environmental pollution. It is expected that within 10 years textile production will be shifted substantially due to increasing governmental and environmental restrictions and the availability of fresh water. Enzyme technology is a promising technology to fulfill expected future requirements and it is one way to attain leadership in traditional textile wet processing areas by both protecting the environment and reducing energy and chemical needs.